Statements (60)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:product
gptkb:patches |
gptkbp:administered_by |
licensed practitioners
|
gptkbp:approves |
gptkb:FDA
|
gptkbp:available_in |
syringe form
|
gptkbp:can_be_combined_with |
other Juvederm products
|
gptkbp:can_cause |
allergic reactions
|
gptkbp:clinical_trial |
studied for safety and efficacy
|
gptkbp:clinical_use |
aesthetic medicine
|
gptkbp:contains |
hyaluronic acid
|
gptkbp:cross_linking_technology |
Vycross technology
|
gptkbp:customer_satisfaction |
high
|
gptkbp:duration |
up to 12 months
|
gptkbp:follow_up_treatment |
recommended after 6-12 months
|
gptkbp:formulation |
injectable gel
|
https://www.w3.org/2000/01/rdf-schema#label |
Juvederm Volbella
|
gptkbp:is_available_in |
gptkb:various_countries
|
gptkbp:is_considered |
non-surgical procedure
temporary filler |
gptkbp:is_often_accompanied_by |
gptkb:Botox
|
gptkbp:is_part_of |
anti-aging treatments
Juvederm product line |
gptkbp:is_popular_in |
aesthetic clinics
|
gptkbp:is_recommended_by |
dermatologists
plastic surgeons |
gptkbp:is_recommended_for |
adults over 21
|
gptkbp:is_subject_to |
regulatory approval
|
gptkbp:is_used_for |
facial contouring
volume loss correction |
gptkbp:is_used_in |
cosmetic dermatology
|
gptkbp:marketed_as |
gptkb:women
gptkb:Volbella_XC men |
gptkbp:p_hlevel |
physiological p H
|
gptkbp:premiered_on |
immediate
|
gptkbp:price |
varies by provider
|
gptkbp:produced_by |
gptkb:Allergan
|
gptkbp:requires |
informed consent
professional administration |
gptkbp:side_effect |
bruising
swelling redness pain at injection site |
gptkbp:storage |
refrigerated
|
gptkbp:suitable_for |
autoimmune diseases
pregnant women people with bleeding disorders people with severe allergies nursing mothers active infections at injection site keloid scarring history |
gptkbp:used_for |
lip enhancement
wrinkle treatment |
gptkbp:viscosity_grade |
low
|
gptkbp:website |
needle
lips microcannula perioral area |
gptkbp:bfsParent |
gptkb:Juvederm
|
gptkbp:bfsLayer |
6
|